A citation-based method for searching scientific literature

Stephanie L Graff, Jared M Holder, Lindsay E Sears, Dax Kurbegov. JCO Oncol Pract 2020
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of patient navigation with care coordination in an Lynch syndrome screening program.
Susan Miesfeldt, W Gregory Feero, Frances L Lucas, Karen Rasmussen. Transl Behav Med 2018
7
100

A systematic review of factors that act as barriers to patient referral to genetic services.
Türem Delikurt, Graham R Williamson, Violetta Anastasiadou, Heather Skirton. Eur J Hum Genet 2015
73
100

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
50

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Karen H Lu, Mai Dinh, Wendy Kohlmann, Patrice Watson, Jane Green, Sapna Syngal, Prathap Bandipalliam, Lee-May Chen, Brian Allen, Peggy Conrad,[...]. Obstet Gynecol 2005
222
50


Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.
Brittany A L Batte, Amanda S Bruegl, Molly S Daniels, Kari L Ring, Katherine M Dempsey, Bojana Djordjevic, Rajyalakshmi Luthra, Bryan M Fellman, Karen H Lu, Russell R Broaddus. Gynecol Oncol 2014
56
50


Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Alyssa Kne, Heather Zierhut, Shari Baldinger, Karen K Swenson, Pamela Mink, Patricia McCarthy Veach, Michaela L Tsai. J Genet Couns 2017
16
50

Genetic testing for Lynch syndrome in the province of Ontario.
Marina Wang, Saud Aldubayan, Ashton A Connor, Beatrix Wong, Kate Mcnamara, Tahsin Khan, Kara Semotiuk, Sam Khalouei, Spring Holter, Melyssa Aronson,[...]. Cancer 2016
7
50

Methodologic challenges in disseminating evidence-based interventions to promote physical activity.
Borsika A Rabin, Ross C Brownson, Jon F Kerner, Russell E Glasgow. Am J Prev Med 2006
81
50

Cancer risk in Lynch Syndrome.
Emma Barrow, James Hill, D Gareth Evans. Fam Cancer 2013
105
50

Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.
Stephanie A Cohen, Angela Bradbury, Vida Henderson, Kent Hoskins, Erica Bednar, Banu K Arun. Am Soc Clin Oncol Educ Book 2019
19
50

Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
Soyoun Rachel Kim, Alicia Tone, Raymond H Kim, Matthew Cesari, Blaise A Clarke, Lua Eiriksson, Tae Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn,[...]. Cancer 2020
5
50

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
919
50

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.
T Pal, M R Akbari, P Sun, J-H Lee, J Fulp, Z Thompson, D Coppola, S Nicosia, T A Sellers, J McLaughlin,[...]. Br J Cancer 2012
48
50

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
576
50

Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges.
Evelyn Marquez, Zhuo Geng, Sarah Pass, Pia Summerour, Linda Robinson, Venetia Sarode, Samir Gupta. Genet Med 2013
19
50

Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
Lua Eiriksson, Melyssa Aronson, Blaise Clarke, Golnessa Mojtahedi, Christine Massey, Amit M Oza, Steven Gallinger, Aaron Pollett, Helen Mackay, Marcus Q Bernardini,[...]. Gynecol Oncol 2015
6
50

Knowledge, attitudes, and perceived barriers towards genetic testing across three rural Illinois communities.
A J Fogleman, W E Zahnd, A E Lipka, R S Malhi, S Ganai, K R Delfino, W D Jenkins. J Community Genet 2019
3
50

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
61
50

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
Daniel D Buchanan, Yen Y Tan, Michael D Walsh, Mark Clendenning, Alexander M Metcalf, Kaltin Ferguson, Sven T Arnold, Bryony A Thompson, Felicity A Lose, Michael T Parsons,[...]. J Clin Oncol 2014
127
50

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Sarah E Ferguson, Melyssa Aronson, Aaron Pollett, Lua R Eiriksson, Amit M Oza, Steven Gallinger, Jordan Lerner-Ellis, Zahra Alvandi, Marcus Q Bernardini, Helen J MacKay,[...]. Cancer 2014
73
50

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Gastroenterology 2014
234
50

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
Steven J Katz, Kevin C Ward, Ann S Hamilton, M Chandler Mcleod, Lauren P Wallner, Monica Morrow, Reshma Jagsi, Sarah T Hawley, Allison W Kurian. J Clin Oncol 2018
36
50

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, Debra L Richardson. Gynecol Oncol 2015
154
50

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.
Cecelia A Bellcross, Sara R Bedrosian, Elvan Daniels, Debra Duquette, Heather Hampel, Kory Jasperson, Djenaba A Joseph, Celia Kaye, Ira Lubin, Laurence J Meyer,[...]. Genet Med 2012
67
50

Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
Josephine Shaw, Caroline Bulsara, Paul A Cohen, Madeleine Gryta, Cassandra B Nichols, Lyn Schofield, Sarah O'Sullivan, Nicholas Pachter, Sarah J Hardcastle. Patient Educ Couns 2018
13
50

Microsatellite instability testing and its role in the management of colorectal cancer.
Hisato Kawakami, Aziz Zaanan, Frank A Sinicrope. Curr Treat Options Oncol 2015
167
50


Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Ravi N Sharaf, Parvathi Myer, Christopher D Stave, Lisa C Diamond, Uri Ladabaum. Clin Gastroenterol Hepatol 2013
78
50

Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.
Soyoun Rachel Kim, Alicia Tone, Raymond Kim, Matthew Cesari, Blaise Clarke, Lua Eiriksson, Tae Hart, Melyssa Aronson, Spring Holter, Alice Lytwyn,[...]. Int J Gynecol Cancer 2020
1
100

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.
H T Lynch, P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland. Clin Genet 2009
484
50

Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
Peter F Rambau, Máire A Duggan, Prafull Ghatage, Khadija Warfa, Helen Steed, Renee Perrier, Linda E Kelemen, Martin Köbel. Histopathology 2016
39
50

Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Deborah Cragun, Rita D DeBate, Susan T Vadaparampil, Julie Baldwin, Heather Hampel, Tuya Pal. Genet Med 2014
45
50

The impact of a genetics education program on physicians' knowledge and genetic counseling referral patterns.
Jonathan C Clyman, Fiza Nazir, Sharon Tarolli, Elizabeth Black, Roni Q Lombardi, Joseph J Higgins. Med Teach 2007
17
50

Missed opportunities: unidentified genetic risk factors in prenatal care.
Trissa McClatchey, Erica Lay, Melissa Strassberg, Ignatia B Van den Veyver. Prenat Diagn 2018
5
50

Process evaluation in randomised controlled trials of complex interventions.
Ann Oakley, Vicki Strange, Chris Bonell, Elizabeth Allen, Judith Stephenson. BMJ 2006
668
50


Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.
Enola Proctor, Hiie Silmere, Ramesh Raghavan, Peter Hovmand, Greg Aarons, Alicia Bunger, Richard Griffey, Melissa Hensley. Adm Policy Ment Health 2011
50

Are interventions theory-based? Development of a theory coding scheme.
Susan Michie, Andrew Prestwich. Health Psychol 2010
328
50

From Theory-Inspired to Theory-Based Interventions: A Protocol for Developing and Testing a Methodology for Linking Behaviour Change Techniques to Theoretical Mechanisms of Action.
Susan Michie, Rachel N Carey, Marie Johnston, Alexander J Rothman, Marijn de Bruin, Michael P Kelly, Lauren E Connell. Ann Behav Med 2018
113
50

Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.
Erica M Bednar, Charlotte C Sun, Bethsaida Camacho, John Terrell, Alyssa G Rieber, Lois M Ramondetta, Ralph S Freedman, Karen H Lu. Gynecol Oncol 2019
3
50

Referral for genetic counselling during pregnancy: limited alertness and awareness about genetic risk factors among GPs.
Cora M Aalfs, Ellen M A Smets, Hanneke C J M de Haes, Nico J Leschot. Fam Pract 2003
26
50

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
50


Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
33
50

Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.
F G J Kallenberg, C M Aalfs, F O The, C A Wientjes, A C Depla, M W Mundt, P M M Bossuyt, E Dekker. Fam Cancer 2018
7
50

Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location.
Christine E Koil, Jessica N Everett, Leah Hoechstetter, Rick E Ricer, Karen M Huelsman. Genet Med 2003
34
50


Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
Amar U Kishan, Caitlin L Gomez, Nicole A Dawson, Robyn Dvorak, Nova M Foster, Anne Hoyt, Sara A Hurvitz, Amy Kusske, Erica L Silver, Charles Tseng,[...]. Ann Surg Oncol 2016
7
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.